These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 17760888

  • 1. The discovery of prostate-specific antigen.
    Rao AR, Motiwala HG, Karim OM.
    BJU Int; 2008 Jan; 101(1):5-10. PubMed ID: 17760888
    [Abstract] [Full Text] [Related]

  • 2. Prostatic specific antigen. From its early days until becoming a prostate cancer biomarker.
    Dellavedova T.
    Arch Esp Urol; 2016 Jan; 69(1):19-23. PubMed ID: 26856734
    [Abstract] [Full Text] [Related]

  • 3. Prostate-specific antigen kinetics in localized and advanced prostate cancer.
    Fitzpatrick JM, Banu E, Oudard S.
    BJU Int; 2009 Mar; 103(5):578-87. PubMed ID: 19210674
    [Abstract] [Full Text] [Related]

  • 4. The discovery of prostate specific antigen as a biomarker for the early detection of adenocarcinoma of the prostate.
    Makarov DV, Carter HB.
    J Urol; 2006 Dec; 176(6 Pt 1):2383-5. PubMed ID: 17085105
    [Abstract] [Full Text] [Related]

  • 5. Separation of enzymatically active and inactive prostate-specific antigen (PSA) by peptide affinity chromatography.
    Wu P, Stenman UH, Pakkala M, Närvänen A, Leinonen J.
    Prostate; 2004 Mar 01; 58(4):345-53. PubMed ID: 14968435
    [Abstract] [Full Text] [Related]

  • 6. PSA and other tissue kallikreins for prostate cancer detection.
    Stephan C, Jung K, Lein M, Diamandis EP.
    Eur J Cancer; 2007 Sep 01; 43(13):1918-26. PubMed ID: 17689069
    [Abstract] [Full Text] [Related]

  • 7. Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins.
    Peracaula R, Tabarés G, Royle L, Harvey DJ, Dwek RA, Rudd PM, de Llorens R.
    Glycobiology; 2003 Jun 01; 13(6):457-70. PubMed ID: 12626390
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of prostate-specific antigen (PSA) membrane test assays for the forensic identification of seminal fluid.
    Hochmeister MN, Budowle B, Rudin O, Gehrig C, Borer U, Thali M, Dirnhofer R.
    J Forensic Sci; 1999 Sep 01; 44(5):1057-60. PubMed ID: 10486959
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fast and novel purification method to obtain the prostate specific antigen (PSA) from human seminal plasma.
    Acevedo B, Perera Y, Torres E, Pentón D, Ayala M, Gavilondo J.
    Prostate; 2006 Jul 01; 66(10):1029-36. PubMed ID: 16598740
    [Abstract] [Full Text] [Related]

  • 17. Indications and timing for prostate biopsy, diagnosis of early stage prostate cancer and its definitive treatment: a clinical conundrum in the PSA era.
    Punnen S, Nam RK.
    Surg Oncol; 2009 Sep 01; 18(3):192-9. PubMed ID: 19282170
    [Abstract] [Full Text] [Related]

  • 18. Prostate specific antigen inhibits immune responses in vitro: a potential role in prostate cancer.
    Kennedy-Smith AG, McKenzie JL, Owen MC, Davidson PJ, Vuckovic S, Hart DN.
    J Urol; 2002 Aug 01; 168(2):741-7. PubMed ID: 12131362
    [Abstract] [Full Text] [Related]

  • 19. Contamination of purified prostate-specific antigen preparations by kallikrein hK2.
    Frenette G, Gervais Y, Tremblay RR, Dubé JY.
    J Urol; 1998 Apr 01; 159(4):1375-8. PubMed ID: 9507887
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.